Top News

• Amgens Uplizna OKd for Immunoglobulin G4 Disease
• Could HHS Mea Culpa Lead to FDA Rehires?
• House Committee Hearing on Reducing FDA Inefficiencies
• Marks: RFK Jr. Wants FDA to Support Stem-cell Treatments
• Draeger Recalls Flex 220 Breathing Circuit
• Breakthrough Status for Uveal Melanoma Therapy
• CRL for Aldeyras Reproxalap for Dry Eye
• Reorganization Will Block Information Flow